High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes

This publication has 36 references indexed in Scilit:

• Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump
  Contact Dermatitis, 2018
• High frequencies of dermatological complications in children using insulin pumps or sensors
  Pediatric Diabetes, 2018
• Being mothers and fathers of a child with type 1 diabetes aged 1 to 7 years: a phenomenological study of parents’ experiences
  International Journal of Qualitative Studies on Health and Well-being, 2018
• Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes
  JAMA, 2017
• Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor
  Contact Dermatitis, 2017
• Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
  BMC Pediatrics, 2016
• Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data
  BMJ, 2011
• Health-related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions
  Pediatric Diabetes, 2011
• Adverse effects of topical glucocorticosteroids
  Journal of the American Academy of Dermatology, 2006
• Contact allergy to components of glue in insulin pump infusion sets
  Contact Dermatitis, 1995